Pollen grains for oral vaccination

Journal of Controlled Release

Volumn 194, Issue , 2014, Pages 45-52

  Atwe, Shashwati U ^a   Ma, Yunzhe ^a   Gill, Harvinder Singh ^a  

^a Texas Tech University   (United States)

Author keywords

Lycopodium spores; Mucosal vaccination; Oral vaccination; Pollen shells; Sporopollenin

Indexed keywords

LYCOPODIUM SPORES; MUCOSAL VACCINATION; ORAL VACCINATIONS; POLLEN SHELLS; SPOROPOLLENIN;

ADJUVANT; ANTIGEN; CHOLERA TOXIN; GRASS POLLEN VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; OVALBUMIN; ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FECES LEVEL; FEMALE; GRAIN; IMMUNE RESPONSE; IMMUNIZATION; INTESTINE WALL; LYCOPODIUM; MOLECULE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; POLLEN; STOMACH ACID; VACCINATION; ANIMAL; BACTERIAL SPORE; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; INTESTINE ABSORPTION; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PROCEDURES; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; CHEMISTRY, PHARMACEUTICAL; FEMALE; GASTRIC ACID; IMMUNITY, MUCOSAL; IMMUNIZATION; INTESTINAL ABSORPTION; LYCOPODIUM; MICE; MICE, INBRED BALB C; OVALBUMIN; POLLEN; SPORES; VACCINATION;

EID: 84907221179     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.08.010     Document Type: Article

References (48)

1. M.T. De Magistris Mucosal delivery of vaccine antigens and its advantages in pediatrics Adv. Drug Deliv. Rev. 58 2006 52 67
2. M.R. Neutra, and P.A. Kozlowski Mucosal vaccines: the promise and the challenge Nat. Rev. Immunol. 6 2006 148 158
3. D.W. Acheson, and S. Luccioli Microbial-gut interactions in health and disease. Mucosal immune responses Best Pract. Res. Clin. Gastroenterol. 18 2004 387 404
4. L.X. Yu, E. Lipka, J.R. Crison, and G.L. Amidon Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption Adv. Drug Deliv. Rev. 19 1996 359 376
5. G. Kersten, and H. Hirschberg Antigen delivery systems Expert Rev. Vaccines 3 2004 453 462
6. J. Holmgren, and C. Czerkinsky Mucosal immunity and vaccines Nat. Med. 11 2005 S45 S53
7. M.A. Clark, M.A. Jepson, and B.H. Hirst Exploiting M cells for drug and vaccine delivery Adv. Drug Deliv. Rev. 50 2001 81 106
8. J. Holmgren, A.M. Harandi, and C. Czerkinsky Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA Expert Rev. Vaccines 2 2003 205 217
9. R. Rappuoli, M. Pizza, G. Douce, and G. Dougan Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins Immunol. Today 20 1999 493 500
10. M.M. Levine, J.B. Kaper, R.E. Black, and M.L. Clements New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development Microbiol. Rev. 47 1983 510 550
11. K.A. Woodrow, K.M. Bennett, and D.D. Lo Mucosal vaccine design and delivery Annu. Rev. Biomed. Eng. 14 2012 17 46
12. S.P. Schwendeman Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems Crit. Rev. Ther. Drug Carrier Syst. 19 2002 73 98
13. T. Nochi, H. Takagi, Y. Yuki, L. Yang, T. Masumura, M. Mejima, U. Nakanishi, A. Matsumura, A. Uozumi, T. Hiroi, S. Morita, K. Tanaka, F. Takaiwa, and H. Kiyono Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination Proc. Natl. Acad. Sci. U. S. A. 104 2007 10986 10991
14. T. Pniewski The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects? Int. J. Mol. Sci. 14 2013 1978 1998
15. K.R. Shivanna Pollen Biology and Biotechnology Science Publishers, Enfield, NH, USA 2003
16. T.H. Roulston, and J.H. Cane Pollen nutritional content and digestibility for animals Plant Syst. Evol. 222 2000 187 209
17. S. Barrier Physical and chemical properties of sporopollenin exine particles, in 2008 The University of Hull Hull
18. W. Jorde, and H.F. Linskens Zur persorption von pollen und spoken durch die intake darmschleimhaut Acta Allergol. 29 1974 165 175
19. M. Lorch, M.J. Thomasson, A. Diego-Taboada, S. Barrier, S.L. Atkin, G. Mackenzie, and S.J. Archibald MRI contrast agent delivery using spore capsules: controlled release in blood plasma Chem. Commun. 2009 6442 6444
20. S. Barrier, A.S. Rigby, A. Diego-Taboada, M.J. Thomasson, G. Mackenzie, and S.L. Atkin Sporopollenin exines: a novel natural taste masking material LWT Food Sci. Technol. 43 2010 73 76
21. V.N. Paunov, G. Mackenzie, and S.D. Stoyanov Sporopollenin micro-reactors for in-situ preparation, encapsulation and targeted delivery of active components J. Mater. Chem. 17 2007 609 612
22. A. Wakil, G. Mackenzie, A. Diego-Taboada, J. Bell, and S. Atkin Enhanced bioavailability of eicosapentaenoic acid from fish oil after encapsulation within plant spore exines as microcapsules Lipids 45 2010 645 649
23. S. Barrier, A. Diego-Taboada, M.J. Thomasson, L. Madden, J.C. Pointon, J.D. Wadhawan, S.T. Beckett, S.L. Atkin, and G. Mackenzie Viability of plant spore exine capsules for microencapsulation J. Mater. Chem. 21 2011 975 981
24. S.L. Atkin, S. Barrier, Z. Cui, P.D.I. Fletcher, G. Mackenzie, V. Panel, V. Sol, and X. Zhang UV and visible light screening by individual sporopollenin exines derived from Lycopodium clavatum (club moss) and Ambrosia trifida (giant ragweed) J. Photochem. Photobiol. B 102 2011 209 217
25. S.T.B., Stephen Lawrence Atkin, and Grahame Mackenzie Dosage form, in, USA 2005 9
26. T.G. Lauterslager, W. Stok, and L.A. Hilgers Improvement of the systemic prime/oral boost strategy for systemic and local responses Vaccine 21 2003 1391 1399
27. M. Vajdy, and N.Y. Lycke Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization Immunology 75 1992 488 492
28. M. Marinaro, H.F. Staats, T. Hiroi, R.J. Jackson, M. Coste, P.N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J.R. McGhee Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4 J. Immunol. 155 1995 4621 4629
29. M. Hesse, H. Halbritter, M. Weber, R. Buchner, A. Frosch-Radivo, and S. Ulrich Pollen terminology: an illustrated handbook 2009 Springer, Wien New York
30. E. Hose, D.T. Clarkson, E. Steudle, L. Schreiber, and W. Hartung The exodermis: a variable apoplastic barrier J. Exp. Bot. 52 2001 2245 2264
31. J.R. Rowley, J.J. Skvarla, and G. El-Ghazaly Transfer of material through the microspore exine from the loculus into the cytoplasm Can. J. Bot. 81 2003 1070 1082
32. J. Wittborn, K.V. Rao, G. El-Ghazaly, and J.R. Rowley Nanoscale similarities in the substructure of the exines of fagus pollen grains and lycopodium spores Ann. Bot. 82 1998 141 145
33. M. Larche, C.A. Akdis, and R. Valenta Immunological mechanisms of allergen-specific immunotherapy Nat. Rev. Immunol. 6 2006 761 771
34. E. Taudorf, L.C. Laursen, R. Djurup, E. Kappelgaard, C.T. Pedersen, M. Søsborg, P. Wilkinson, and B. Weeke Oral administration of grass pollen to hay fever patients Allergy 40 1985 321 335
35. E. Taudorf, and B. Weeke Orally Administered Grass Pollen Allergy 38 1983 561 564
36. R. Urbanek, K.H. Bürgelin, S. Kahle, W. Kuhn, and U. Wahn Oral immunotherapy with grass pollen in enterosoluble capsules Eur. J. Pediatr. 149 1990 545 550
37. H.F. Linskens, and W. Jorde Pollen as food and medicine: a review Econ. Bot. 51 1997 78 86
38. I. Orhan, E. Kupeli, B. Sener, and E. Yesilada Appraisal of anti-inflammatory potential of the clubmoss, Lycopodium clavatum L. J. Ethnopharmacol. 109 2007 146 150
39. K. Tochikubo, M. Isaka, Y. Yasuda, S. Kozuka, K. Matano, Y. Miura, and T. Taniguchi Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin Vaccine 16 1998 150 155
40. T. Vesikari Rotavirus vaccination: a concise review Clin. Microbiol. Infect. 18 Suppl. 5 2012 57 63
41. I.J. Amanna, N.E. Carlson, and M.K. Slifka Duration of humoral immunity to common viral and vaccine antigens N. Engl. J. Med. 357 2007 1903 1915
42. J. Banatvala, P. Van Damme, and S. Oehen Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory Vaccine 19 2000 877 885
43. T.M. Cook, R.T. Protheroe, and J.M. Handel Tetanus: a review of the literature Br. J. Anaesth. 87 2001 477 487
44. K.E. Carr, R.A. Hazzard, S. Reid, and G.M. Hodges The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes Pharm. Res. 13 1996 1205 1209
45. G. Volkheimer Passage of particles through the wall of the gastrointestinal tract Environ. Health Perspect. 9 1974 215 225
46. S.H. Smyth, S. Feldhaus, U. Schumacher, and K.E. Carr Uptake of inert microparticles in normal and immune deficient mice Int. J. Pharm. 346 2008 109 118
47. G. Volkheimer, and F.H. Schulz The phenomenon of persorption Digestion 1 1968 213 218
48. Y.J.F. Hutin, A.M. Hauri, and G.L. Armstrong Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates BMJ 327 2003 1075